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SUmmAry – Postpericardiotomy syndrome (PPS) is worsening or new formation of pericardial 
and/or pleural effusion mostly 1 to 6 weeks after cardiac surgery, as a result of autoimmune inflamma-
tory reaction within pleural and pericardial space. its incidence varies among different studies and 
registries (2% to 30%), as well as according to the type of cardiac surgery performed. we conducted 
this retrospective analysis of PPS incidence and diagnostic and treatment strategies in patients re-
ferred for cardiac surgery for revascularization, valvular and/or aortic surgery. we retrospectively ana-
lyzed 461 patients referred for an urgent or elective cardiac surgery procedure between 2009 and 2015. 
PPS diagnosis was established using well defined clinical criteria. demographic and clinical charac-
teristics were used in regression subanalysis among patients having undergone surgery of aortic valve 
and/or ascending aorta. within 6 weeks after cardiac surgery, 47 (10.2%) patients had PPS. The me-
dian time from the procedure to PPS diagnosis was 14 days. The incidence of PPS was 26% after 
aortic valve and/or aorta surgery, and 7.9% and 8.3% after coronary bypass and mitral valve surgery, 
respectively. Among patients subjected to aortic valve and/or aortic surgery, regression analysis showed 
significant association of fever, C-reactive protein (CrP) elevation between 5 and 100 mg/l, urgent 
procedure and postoperative antibiotic use with PPS diagnosis, whereas younger age showed near-
significant association. All patients had complete resolution of PPS, mostly after corticosteroid thera-
py, with only 2 cases of recurrent PPS that successfully resolved after colchicine therapy. Pleural drain-
age was indicated in 15 (32%) patients, whereas only one patient required pericardial drainage. in 
conclusion, PPS incidence in our retrospective analysis was similar to previous reports. Patients having 
undergone aortic valve and/or aortic surgery were most likely to develop PPS. The most relevant 
clinical criteria for diagnosis in these patients were fever, CrP elevation between 5 and 100 mg/l, and 
pericardial and/or pleural effusion formation or worsening 2 weeks after cardiac surgery.
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Introduction
Postpericardiotomy syndrome (PPS) is a clinical 
syndrome consisting of worsening or new formation of 
pericardial and/or pleural effusion, pericardial rub, 
chest pain with or without dyspnea, fever, and elevated 
inflammatory markers. it occurs mostly 1 to 6 weeks 
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after cardiac surgery as a result of inflammatory reac-
tion after surgical cutdown of pericardial space. Patho-
physiology research demonstrated antibodies in pa-
tients with PPS, thus explaining the syndrome with 
autoimmune response. Surgical aperture of pericardial 
space causes tissue damage, bleeding and formation of 
a certain amount of new fluid that normally resolves 
within 4 weeks. in PPS, tissue damage triggers auto-
immune reaction of the pericardium and pleura that 
occurs mostly between 1 and 6 weeks after the proce-
dure.
Postpericardiotomy syndrome is considered as one 
of the most common complications of cardiac surgery 
in the late postoperative period. its incidence is close 
to 10% but varies among different studies and regis-
tries (2% to 30%), as well as according to the type of 
cardiac surgery performed1.
The incidence, diagnostic procedures and treat-
ment strategies have been well defined to date1,2, with 
most interesting studies on the prevention of PPS us-
ing anti-inflammatory medication in perioperative 
 period for the prevention of PPS3. early diagnosis is 
essential in the prevention of potential serious com-
plications. Although most patients have an uncom-
plicated clinical course with good prognosis after ad-
ministration of nonsteroidal anti-inflammatory drugs 
(nSAids), corticosteroids or colchicine, some studies 
report cases of patients with late diagnosis that re-
quired pericardial drainage or even redo surgery4.
we conducted this retrospective analysis of PPS 
incidence, risk factors, treatment strategies and treat-
ment response in patients referred for cardiac surgery 
for revascularization, valvular and/or aortic surgery.
Patients and Methods
Patients
we retrospectively analyzed hospital records of 461 
patients referred for cardiac surgery from dr. Josip 
benčević general Hospital, Slavonski brod, Croatia to 
dubrava University Hospital, Zagreb, Croatia, be-
tween march 2009 and October 2015. The median age 
of all patients was 69 years, with 64% of male patients. 
isolated coronary artery bypass graft (CAbg) surgery 
was performed in 379 (82%) patients, whereas 58 
(13%) patients underwent aortic valve or aorta surgery 
with or without CAbg and 24 (5%) patients had mi-
tral valve surgery with or without CAbg. diabetes 
mellitus was present in 24% of patients, whereas 17% 
and 5% of patients had chronic renal insufficiency and 
chronic obstructive pulmonary disease (COPd), re-
spectively.
PPS diagnosis
identical diagnostic algorithm was set for all pa-
tients throughout the observed period, and was based 
on a clinical diagnosis of moderate or severe PPS re-
quiring medical attention. PPS diagnosis was estab-
lished in patients with new or worsened pericardial 
effusion greater than 5 mm on echocardiography and/
or new or worsened pleural effusion confirmed by 
chest x-ray within 6 weeks after pericardiotomy car-
diac surgery procedure that had at least one of the fol-
lowing additional clinical signs: fever with no obvious 
infection, elevation of C-reactive protein (CrP) with 
no obvious infection, pleuritic chest pain, and pericar-
dial rub. Also, PPS diagnosis was also established in 
patients with pericardial and/or pleural effusion after 
cardiac surgery with non-confirmed etiology that re-
sponded well to nSAid, corticosteroid or colchicine 
therapy. All echocardiographic analyses were per-
formed on a vivid 4 (general electric, USA). CrP 
was determined in plasma using standard biochemical 
method and expressed in mg/l. in case of pleural or 
pericardial drainage, lactate dehydrogenase, total pro-
tein and albumin levels were identified in drained fluid 
and plasma using standard biochemical methods and 
analyzed using light criteria5.
Subanalysis of patients referred for aortic valve  
or aorta surgery
demographic and clinical characteristics of 58 pa-
tients referred for aortic valve or aorta surgery were 
analyzed in regard to PPS occurrence between 1 and 6 
weeks after the procedure.
Statistical analysis
Continuous variables were expressed as median 
and range, and categorical variables as percentages. The 
χ2-test was used to determine difference in proportions 
between the groups. multivariable Cox regression was 
used to analyze the impact of the main demographic 
and clinical characteristics on the incidence of PPS in 
patients undergoing surgery of the aorta and aortic 
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valve. Statistical significance was set at p<0.05. Statis-
tical analysis was performed using SPSS 12.0 software 
(ibm, USA).
Results
Out of a total of 461 patients referred for cardiac 
surgery between 2009 and 2015, moderate or severe 
form of PPS that required medical attention was diag-
nosed in 47 (10.2%) patients. The average time from 
the surgery to the onset of the disease was 14 days. 
Features of patients with the criteria for PPS diagnosis 
are shown in table 1.
Patients having undergone aortic valve/aorta sur-
gery had the highest incidence of PPS and were se-
lected for additional regression analysis of factors as-
sociated with confirmed PPS diagnosis. Among pa-
tients undergoing surgery of the aortic valve and/or 
aorta, regression analysis showed fever, elevated CrP 
between 5 and 100 mg/l, an emergency procedure 
and postoperative use of antibiotics to be independent 
risk factors for PPS. younger age was also prominently 
associated with a higher frequency of PPS; however, it 
did not reach statistical significance (table 2).
Discussion
Postpericardiotomy syndrome is one of the most 
common cardiac surgery complications in the late 
postoperative period. retrospective analysis of our 
data demonstrated the overall incidence of PPS of 
10.2%, very rare need of pericardiocentesis, and overall 
good prognosis after medical therapy, which corre-
sponded to previous studies6. Corticosteroids were 
used in medical therapy in most patients. Previous 
studies describe more common administration of 
nSAids in mild forms of the disease, whereas moder-
ate to serious forms of PPS were treated with cortico-
steroids, or lately more frequently with colchicine in 
combination with nSAids6,7.
Table 1. Clinical characteristics of 47 patients with 
postpericardiotomy syndrome treated between March 
2009 and October 2015
Clinical characteristic number (%)
Age (years), median (range) 61 (65)
gender, male 35 (74)
time to diagnosis (days),  
median (range) 14 (33)
Fever 19 (40)
C-reactive protein (mg/l),  
median (range) 53 (114)
diabetes mellitus type 2 10 (21)
Chronic renal insufficiency 9 (19)
Pleural effusion 40 (85)
Pericardial effusion 35 (74)
Pleural percutaneous drainage 15 (32)
Pericardial percutaneous drainage 1 (2)
Fig. 1. Significantly higher proportion of 
postpericardiotomy syndrome among patients referred  
for surgery of the aortic valve and/or thoracic aorta 
compared to coronary artery bypass graft and mitral 
valve surgery.
differences in the frequency of PPS depending on 
the type of cardiac procedure are shown in Figure 1. 
PPS incidence after aortic valve and/or aorta surgery 
was 26%, whereas its incidence after isolated aorto-
coronary bypass surgery or mitral valve surgery was 
significantly lower (Fig. 1).
All patients achieved remission after conservative 
medical therapy, most commonly with corticosteroids 
in 36 (77%) patients, and with nSAids or colchicine 
in 11 (23%) patients. There were two documented cas-
es of recurrence of the disease after initial corticoste-
roid therapy, which were successfully treated with col-
chicine. in 15 (32%) patients, pleural drainage was 
performed due to large pleural effusion, whereas only 
one (2%) patient needed pericardiocentesis.
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in this study, a significantly higher proportion of 
PPS was recorded among patients undergoing surgery 
of the aortic valve and/or aorta, with or without 
CAbg, compared to patients referred for other types 
of cardiac surgery. to date, there are no relevant studies 
analyzing differences in the incidence of PPS depend-
ing on the type of surgical procedure. in their prospec-
tive study, imazio et al. report a higher incidence of 
PPS in females and in patients that had perioperative 
incision of the pleura8, whereas a Finnish group of au-
thors found that PPS was more frequently present in 
patients receiving blood transfusions and in diabetic 
patients not treated with metformin6. However, there 
are no analyses of difference in the incidence of PPS 
among patients with coronary, mitral, or aortic surgical 
procedures. Our results showed a significant impact of 
emergency surgery and postoperative use of antibiot-
ics, while age younger than 65 was close to statistical 
significance as an independent risk factor for PPS.
Since we showed a significantly higher incidence of 
PPS among patients having undergone surgery of the 
aorta and aortic valve, we assume that patients referred 
Table 2. Risk factors associated with postpericardiotomy syndrome development in 58 patients referred for aortic valve 
surgery and/or thoracic aorta surgery
Clinical characteristic
PPS




Age (years), median (range) 65 (51) 69 (51) 0.055 1.136 (0.978-1.264)
gender, n (%) male 8 (53) 29 (67) 0.328 0.552 (0.166-1.829)Female 7 (47) 14 (33)
nyHA ≥3, n (%) yes 13 (87) 34 (79) 0.506 1.721 (0.327-9.050)no 2 (13) 9 (21)
lveF <50, n (%) yes 5 (33) 8 (19) 0.252 2.188 (0.584-8.189no 10 (67) 35 (81)
Coronary artery disease,  
n (%)
yes 7 (47) 17 (39) 0.630 1.338 (0.409-4.374)no 8 (53) 26 (61)
diabetes mellitus type 2, 
n (%)
yes 3 (20) 11 (26) 0.659 0.727 (0.173-3.066)no 12 (80) 32 (74)
Chronic renal insufficiency, 
n (%)
yes 3 (20) 7 (17) 0.746 1.286 (0.286-5.774)no 12 (80) 36 (83)
COPd, n (%) yes 1 (7) 2 (5) 0.767 1.464 (0.123-17.145)no 14 (93) 41 (95)
Urgent procedure, n (%) yes 2 (13) 0 0.018 0.867 (0.711-0.957)no 13 (87) 43 (100)
CAbg, n (%) yes 4 (27) 10 (23) 0.521 1.2 (0.313-4.608)no 11 (73) 33 (77)
mitral valve surgery, n (%) yes 0 2 (5) 0.546 1.049 (0.982-1.120)no 15 (100) 41 (95)
Fever postoperative, n (%) yes 4 (27) 1 (3) 0.013 15.273 (1.547-150.765)no 11 (73) 42 (97)
CrP >5 mg/l, n (%) yes 13 (87) 15 (35) 0.001 12.133 (2.412-61.029)no 2 (13) 28 (65)
Antibiotic postoperative, 
n (%)
yes 7 (47) 5 (12) 0.004 6.650 (1.677-26.357)no 8 (53) 38 (88)
PPS = postpericardiotomy syndrome; nyHA = new york Heart Association functional classification; lveF = left ventricular ejection 
fraction; COPd = chronic obstructive pulmonary disease; CAbg = coronary artery bypass graft; CrP = C-reactive protein
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for this type of surgery may benefit from prophylactic 
treatment with colchicine or corticosteroids. recently, 
there were several randomized trials of PPS preven-
tion with prophylactic medical therapy, and the most 
studied drugs were steroids and colchicine9,10. deCS 
study was the largest randomized trial so far that ex-
amined the effectiveness of intraoperative application 
of 1 mg/kg of dexamethasone to prevent PPS, com-
pared to placebo after cardiac surgery in more than 
4000 patients. it did not justify perioperative use of 
colchicine9. COPPS2 study examined the feasibility of 
prophylactic application of colchicine compared to 
placebo and showed a significant reduction in the inci-
dence of PPS in patients treated with colchicine, but 
no difference in the incidence of significant pleural or 
pericardial effusion, or atrial fibrillation. worth noting 
was the very high incidence of PPS among the 
COPPS2 population (19.4% of patients administered 
colchicine and even 29.4% of patients on placebo)10. 
Consequently, there are still no clear recommenda-
tions on the justification of prophylactic treatment 
with corticosteroids or colchicine in particular groups 
of patients. However, it is important to note that the 
above mentioned studies did not analyze subgroups of 
patients depending on the type of cardiac surgery, with 
a particular focus on patients undergoing surgery of 
the aorta or aortic valve. we hypothesize that patients 
undergoing surgery of the aortic valve and/or thoracic 
aorta have a more profound immune response and are 
more prone to PPS. Calcified aortic stenosis has been 
linked with increased serum concentrations of poten-
tial inflammatory markers in previous studies11. it 
would be interesting to prospectively investigate the 
efficacy of prophylactic treatment with colchicine or 
corticosteroids in this patient population, with analysis 
of the impact of age, sex and other comorbidities on 
the development of PPS.
Our analysis, with important limitations of small 
sample, large confidence intervals and retrospective 
design, showed the incidence of PPS to be similar to 
earlier studies with a relatively benign course of the 
disease. This study has also generated the hypothesis 
that younger patients referred for aortic valve and/or 
thoracic aorta surgery without associated comorbidi-
ties have a higher risk of developing PPS and are an 
interesting group for future analysis of PPS prevention 
with colchicine or corticosteroids.
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Sažetak
POStPeriKArdiOtOmiJSKi SindrOm – UČeStAlOSt, diJAgnOStiČKi KriteriJi  
i liJeČenJe: iSKUStvA SUrAdnJe dvAJU CentArA
K. Gabaldo, Ž. Sutlić, D. Mišković, M. Knežević Praveček, Đ. Prvulović, B. Vujeva,  
K. Cvitkušić Lukenda i I. Hadžibegović
Postperikardiotomijski sindrom (PPS) je pogoršanje ili novo stvaranje perikardijalnog i/ili pleuralnog izljeva uglavnom 1 
do 6 tjedana nakon kardiokirurške operacije, i to kao rezultat autoimune upalne reakcije unutar pleuralnog i perikardijalnog 
prostora. njegova učestalost varira među različitim studijama i registrima (između 2% i 30%), kao i prema vrsti kirurškog 
zahvata koji je proveden. Proveli smo retrospektivnu analizu učestalosti PPS-a i dijagnostičkih i terapijskih strategija u bole-
snika upućenih na kardiokirurgiju radi revaskularizacije, valvularne i/ili kirurgije torakalne aorte. retrospektivno smo anali-
zirali 461 bolesnika upućenog na hitan ili elektivni kardiokirurški zahvat između 2009. i 2015. godine. dijagnoza PPS-a 
utvrđena je pomoću dobro definiranih kliničkih kriterija. demografske i kliničke karakteristike korištene su u regresijskoj 
subanalizi kod bolesnika koji su bili podvrgnuti operaciji aortnog zaliska i/ili uzlazne aorte. U roku od 6 tjedana nakon za-
hvata 47 (10,2%) bolesnika razvilo je PPS. Srednje vrijeme od postupka do dijagnoze PPS bilo je 14 dana. Učestalost PPS-a 
bila je 26% nakon operacije aortnog zaliska i/ili torakalne aorte te 7,9% i 8,3% nakon izoliranog koronarnog premoštenja 
odnosno operacije mitralnog zaliska. među bolesnicima koji su bili podvrgnuti kirurškom zahvatu aortnog zaliska i/ili tora-
kalne aorte regresijska analiza pokazala je značajnu povezanost povišene temperature, povišenja C-reaktivnog proteina 
(CrP) između 5 i 100 mg/l, veće hitnosti zahvata i poslijeoperacijske uporabe antibiotika s PPS-om, dok je za mlađu dob 
ta povezanost bila blizu razine značajnosti. Kod gotovo svih bolesnika došlo je do povlačenja PPS-a i to uglavnom nakon 
terapije kortikosteroidima, pri čemu su samo 2 slučaja rekurentnog PPS-a uspješno liječena kolhicinom. Pleuralna drenaža 
bila je indicirana u 15 (32%) bolesnika, dok je samo jedan bolesnik zahtijevao perikardijalnu drenažu. Zaključno, učestalost 
PPS-a u našoj retrospektivnoj analizi bila je slična prethodnim izvješćima. bolesnici koji su bili podvrgnuti operacijama 
aortnog zaliska i/ili aorte imali su najveću učestalost PPS-a. najrelevantniji klinički kriteriji za postavljanje dijagnoze u tih 
bolesnika su povišena temperatura, povišenje CrP-a između 5 i 100 mg/l te nastanak perikardijalnog i/ili pleuralnog izlje-
va ili njihovo pogoršanje 2 tjedna nakon kirurškog zahvata na srcu.
Ključne riječi: Kardiokirurški postupci; Poslijeoperacijske komplikacije; Perikardijalni izljev; Pleuralni izljev; Postperikardioto-
mijski sindrom
